Developments in Radiotherapy

References

• Mattsson S, Brahme A, Carlsson J, et al. Swedish Cancer Society radiation therapy research investigation. Acta Oncol 2002; 41: 596–603.
   PubMed Web of Science ®Google Scholar
• Zackrisson B, Kjellén E, Glimelius B, Carlsson J, Littbrand B, Turesson I, and the Swedish Cancer Society Investigation Group. Sensitising and protective substances in radiotherapy and predictive assays. Acta Oncol 2002; 41: 615–22.
   Google Scholar
• Zackrisson B, Mattsson S, Kjellén E, Glimelius B, and the Swedish Cancer Society Investigation Group. Research and development of radiation therapy in clinical routines. Acta Oncol 2003; 42: 115–22.
   Google Scholar
• Glimelius B, Nordenskjöld B, Kjellén E, Zackrisson B, and the Swedish Cancer Society Investigation Group. Interactions between chemotherapy, endocrine therapy and radiation. Acta Oncol 2002; 41: 635–8.
   Google Scholar
• Strandqvist M. Studien tiber die kumulative Wirkung der Röntgenstrahlen bei Fraktionierung. Acta Radiol 1944; (Suppl 55): 1–300.
   Google Scholar
• Kellerer AM, Rossi HH. The theory of dual radiation action. Curr Top Radiat Res Quarterly 1972; 8: 85–158.
   Google Scholar
• Chadwick KH, Leenhouts HP. A molecular theory of cell survival. Phys Med Biol 1973; 18: 78–87.
   PubMed Web of Science ®Google Scholar
• Pohlit W, Heyder IR. The shape of dose-survival curves for mammalian cells and repair of potentially lethal damage analyzed by hypertonic treatment. Radiat Res 1981; 87: 613–34.
   PubMed Web of Science ®Google Scholar
• Tobias CA. The repair-misrepair model in radiobiology: comparison to other models. Radiat Res 1985; 104: 77–95.
   Web of Science ®Google Scholar
• Curtis SB. Lethal and potentially lethal lesions induced by radiation - a unified repair model. Radiat Res 1986; 106: 252–70.
   PubMed Web of Science ®Google Scholar
• Chadwick KH, Leenhouts HP. Radiation induced chromosome aberrations: some biophysical considerations. Mutat Res 1998; 404: 113–7.
   PubMedGoogle Scholar
• Barendsen GW. Dose fractionation, dose rate, and isoeffect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 1982; 8: 1981–97.
   PubMed Web of Science ®Google Scholar
• Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 679–94.
   PubMed Web of Science ®Google Scholar
• Denekamp J. Changes in the rate of repopulation during multifraction irradiation of mouse skin. Br J Radiol 1973; 46: 381–7.
   PubMed Web of Science ®Google Scholar
• Fowler JF. Potential for increasing the differential response between tumors and normal tissues: can proliferation rate be used? Int J Radiat Oncol Biol Phys 1986; 12: 641–5.
   PubMedGoogle Scholar
• Nilsson P, Thames HD, Joiner MC. A generalized formulation of the 'incomplete-repair' model for cell survival and tissue response to fractionated low dose-rate irradiation. Int J Radiat Biol 1990; 57: 127–42.
   Google Scholar
• Tucker SL, Travis E. Comments on a time-dependent version of the linear-quadratic model. Radiother Oncol 1990; 18: 155–63.
   PubMed Web of Science ®Google Scholar
• Joiner MC, van der Kogel AJ. The linear-quadratic approach to fractionation and calculation of isoeffect relationships. In: Steel GG, ed. Basic clinical radiobiology, 2nd ed. London: Arnold; 1997. p. 106–21.
   Google Scholar
• Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131–46.
   Google Scholar
• Tucker SL. Pitfalls in estimating the influence of overall treatment time on local tumor control. Acta Oncol 1999; 38: 171–8.
   PubMedGoogle Scholar
• Joiner MC, Denekamp J, Maughan RL. The use of 'top-up' experiments to investigate the effect of very small doses per fraction in mouse skin. Int J Radiat Biol 1986; 49: 565–80.
   Google Scholar
• Lambin P, Malaise EP, Joiner MC. The effect of very low radiation doses on the human bladder carcinoma cell line RT112. Radiother Oncol 1994; 32: 63–72.
   Google Scholar
• Turesson I, Bernefors R, Book M, et al. Normal tissue response to low doses of radiotherapy assessed by molecular markers. A study of skin in patients treated for prostate cancer. Acta Oncol 2001; 40: 941–51.
   Google Scholar
• Wouters BG, Skarsgard LD. The response of a human tumor cell line to low radiation doses: evidence of enhanced sensitiv-ity. Radiat Res 1994; 138: S76–80.
   PubMed Web of Science ®Google Scholar
• Lind BK, Persson LM, Edgren MR, Hedlof I, Brahme A. Repairable conditionally repairable damage model based on dual Poisson processes. Radiat Res 2003 (in press).
   Google Scholar
• Turesson I, Carlsson J, Brahme A, Glimelius B, Zackrisson B, Stenerlöw B, and the Swedish Cancer Society Investigation Group. Biological response to radiation therapy. Acta Oncol 2003; 42: 92–106.
   Google Scholar
• Johansson K-A, Mattsson S, Brahme A, Carlsson J, Zackrisson B, Turesson I, and the Swedish Cancer Society Investigation Group. Radiation therapy dose delivery. Acta Oncol 2003; 42: 85–91.
   Google Scholar
• Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol 1984; 23: 379–91.
   PubMed Web of Science ®Google Scholar
• Agren-Cronquist AK. Qualification of the response of hetero-geneous tumours and organized tissues to fractionated radio-therapy: Stockholm University. Thesis; 1995.
   Google Scholar
• Agren-Cronquist A-K, Källman P, Turesson I, et al. Volume and heterogeneity dependence of dose-response relationship for head and neck tumours. Acta Oncol 1995; 34: 851–60.
   PubMedGoogle Scholar
• Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21: 109–22.
   PubMed Web of Science ®Google Scholar
• van der Kogel AJ. Radiation response and tolerance of normal tissues. In: Steel G, ed. Basic clinical radiobiology. 2nd ed. London: Arnold, 1997. p. 30–40.
   Google Scholar
• Johansson S, Svensson H, Larsson LG, Denekamp J. Brachial plexopathy after postoperative radiotherapy of breast cancer patients - a long-term follow-up. Acta Oncol 2000; 39: 373–82.
   PubMed Web of Science ®Google Scholar
• Barrett A. Recording of late morbidity. Radiother Oncol 2000; 57: S51.
   Google Scholar
• Withers HR, Taylor JMG, Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys 1988; 14: 751–9.
   PubMed Web of Science ®Google Scholar
• Källman P, Agren A, Brahme A. Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Rad Biol 1992; 62: 249–62.
   Google Scholar
• Källman P. Optimization of radiation therapy planning using physical and biological objective functions. Thesis Med Radia-tion Physics, Stockholm University 1992: 1–40.
   Google Scholar
• Lof J. Development of a general framework for optimization of radiation therapy. Thesis Med Radiation Physics: Stockholm University; 2000: 1–43.
   Google Scholar
• Churchill-Davidsson I. The oxygen effect in radiotherapy - historical review. Front Radiat Ther Oncol 1968; 1: 1–15.
   Google Scholar
• Overgaard J, Horsman MR. Overcoming hypoxic cell radio-resistance. In: Steel G, ed. Basic clinical radiobiology. 2nd ed. London: Arnold, 1997. p. 141–51.
   Google Scholar
• Withers HR. The four R's of radiotherapy. Adv Radiat Biol 1975; 5: 241–7.
   Google Scholar
• Littbrand B, Edsmyr F, Revesz L. A low dose-fractionation scheme for the radiotherapy of carcinoma of the bladder. Experimental background and preliminary results. Bull Cancer 1975; 62: 241–8.
   Google Scholar
• Dasu A, Denekamp J. Superfractionation as a potential hypoxic cell radiosensitizer: prediction of an optimum dose per fraction. Int J Radiat Oncol Biol Phys 1999; 43: 1083–94.
   PubMed Web of Science ®Google Scholar
• Joiner C. Hyperfractionation and accelerated radiotherapy. In Steel G, ed. Basic clinical radiobiology. 2nd ed. London: Arnold, 1997. p. 123–31.
   Google Scholar
• Fowler J. Biological factors influencing optimum fractionation in radiation therapy. Acta Oncol 2001; 40: 712–7.
   PubMed Web of Science ®Google Scholar
• Denekamp J, Dasu A. Inducible repair and the two forms of tumour hypoxia - time for a paradigm shift. Acta Oncol 1999; 38: 903–18.
   PubMed Web of Science ®Google Scholar
• AAPM Task group 50. Basic applications of multileaf colli-mators. AAPM Report No 72; 2001: 1–54.
   Google Scholar
• Brahme A. Optimization of stationary and moving beam radiation therapy techniques. Radiother Oncol 1988; 12: 129–40.
   PubMed Web of Science ®Google Scholar
• Muren LP, Mella O, Hafslund R, Dahl O. Norwegian oncologists' expectations of intensity-modulated radiotherapy. Acta Oncol 2002; 41: 562–5.
   PubMedGoogle Scholar
• Karlsson MG, Karlsson M, Ma CM. Treatment head design for multileaf collimated high-energy electrons. Med Phys 1999; 26: 2161–7.
   Google Scholar
• Mackie TR, Holmes T, Swerdloff S, et al. Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys 1993; 20: 1709–19.
   PubMed Web of Science ®Google Scholar
• Svensson R. Development of a compact high energy treatment unit combining narrow pencil beam scanning and multileaf collimation: Thesis Med Radiat Physics, Stockholm University; 1998: 1–37.
   Google Scholar
• Forssell-Aronsson E, Kjellén E, Mattsson S, Hellstrom M, and the Swedish Cancer Society Investigation Group. Medical imaging for improved tumour characterisation, delineation and treatment verification. Acta Oncol 2002; 41: 604–14.
   Google Scholar
• Kessler ML, Ten Haken RK. Use of MRI data for treatment planning. In: Hazle JD, Boyer AL, eds. Imaging radiation therapy. Medical physics monograph. Madison, WI, USA: Med Phys Publishing; 1998. p. 313–40.
   Google Scholar
• Rosenman JG, Miller EP, Tracton G, Cullip TJ. Image registration: an essential part of radiation therapy treatment planning. Int J Radiat Oncol Biol Phys 1998; 40: 197–205.
   PubMedGoogle Scholar
• Chapman JD, Schneider RF, Urbain JL, Hanks GE. Single-photon emission computed tomography and positron-emission tomography assays for tissue oxygenation. Semin Radiat Oncol 2001; 11:47–57.
   PubMedGoogle Scholar
• Olive PL, Bandth JP, Aquino-Parsons C. Measuring hyopoxia in solid tumours. Is there a gold standard? Acta Oncol 2001; 40: 917–23.
   Google Scholar
• Chang J, Mageras GS, Ling CC, Lutz W. An iterative EPID calibration procedure for dosimetric verification that considers the EPID scattering factor. Med Phys 2001; 28: 2247–57.
   PubMedGoogle Scholar
• Gross M, Pavlovic M, eds. Proposal for a dedicated ion beam facility for cancer therapy. Universitätsklinik Heidelberg DKH: Gesellschaft for Schwerionenforschung Darmstadt, 1998; 1–98.
   Google Scholar
• Brahme A. Biologically optimized 3-dimensional in vivo predictive assay based radiation therapy using positron emis-sion tomography-computerized tomography imaging. Acta Oncol 2003; 42: 123–36.
   PubMed Web of Science ®Google Scholar
• Poljanc K, Auberger T. Derzeitiger Stand der Protonen- und Leichtionentherapie in der Welt. In: Potter R, Augberger T, Regler M, eds. Med Austron em n Osterreichisches Krebs-forschung- und Behandlungszentrum zur Hadronentherapie in Europa, Band 1. Wien: 1998. p. 123–8.
   Google Scholar
• Stone MR. Neutron therapy and specific ionization. Am J Roentgenol 1948; 59: 771–85.
   Google Scholar
• Richard F, Wambersie A. Fast neutrons and the LET-factor. In: Amaldi U, Larsson B, eds. Hadrontherapy in Oncology. Excerpta Medica 1994: 173–98.
   Google Scholar
• Brahme A, Lewensohn R, Ringborg U, Amaldi UFG, Rossi S. Design of a centre for biologically optimised light ion therapy in Stockholm. Nucl Inst Meth B 2001; 184: 569–88.
   Google Scholar
• Gerard JP, Remillieux J, Rochat J, Lieuvin F, Terrien Y. ETOILE Project (European Light Ion Oncological Centre), Rapport LYCEN 2002–01 (A, B, C), Université Claude Bernard Lyon CNRS/IN2P3/IPNL. p. 1–73.
   Google Scholar
• Auberger T, Griesmayer E, Potter R. Med. Austron: Statusber-icht 2002.
   Google Scholar
• Tsujii H, Morita S, Miyamoto T, et al. Preliminary results of phase 1/2 carbon-ion therapy at the national institute of radiological sciences. J Brachyther Int 1997; 13: 1–8.
   Google Scholar
• Yamada S. The progress of HIMAC and particle therapy facilities. Chiba, Japan: National Institute of Radiological Sciences; 2001. p. 1–5.
   Google Scholar
• Tsujii H, Morita S, Miyamoto T, et al. Experiences of carbon ion radiotherapy at NIRS National Institute of Radiological Sciences. Chiba, Japan: National Institute of Radiological Sciences; 2001. p. 1–10.
   Google Scholar
• Lorcher GL. Biological effects and therapeutic possibilities of neutrons. AJR 1936; 36: 1–13.
   Google Scholar
• Carlsson J, Forsell-Aronsson E, Mattsson S, Glimelius B, and the Swedish Cancer Society Investigation Group. Radiation therapy through activation of stable nuclides. Acta Oncol 2002; 41: 629–34.
   Google Scholar
• Schulz RJ. Further improvements in dose distributions are unlikely to affect cure rates. Med Phys 1999; 26: 1007–9.
   PubMed Web of Science ®Google Scholar
• Schulz RJ, Kagan AR. On the role of intensity-modulated radiation therapy in radiation oncology. Med Phys 2002; 29: 1473–82.
   PubMedGoogle Scholar
• Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002; 53: 1097–105.
   PubMed Web of Science ®Google Scholar
• Widmark A, Fransson P, Franzen L, Littbrand B, Henriksson R. Daily-diary evaluated side effects of conformal versus conventional prostatic cancer radiotherapy technique. Acta Oncol 1997; 36: 499–507.
   Google Scholar
• Hanks GE, Hanlon AL, Pinover WH, Horwitz EM, Schultheiss TE. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radio-therapy. Cancer J Sci Am 1999; 5: 152–8.
   Google Scholar
• Hendee WR. Moderator point/counterpoint). Intensity-modu-lated conformal radiation therapy and 3-dimensional treatment planning will significantly reduce the need for therapeutic approaches with particles such as protons. Med Phys 1999; 26: 1185.
   Google Scholar
• Mackie TR. For the proposition. Med Phys 1999; 26: 1186.
   Google Scholar
• Smith AR. Against the proposition. Med Phys 1999; 26: 1187.
   Google Scholar
• Brahme A. Development of radiation therapy optimization. Acta Oncol 2000; 39: 579–95.
   PubMed Web of Science ®Google Scholar
• Karlsson M, Zackrisson B. Matching of electron and photon beams with a multi-leaf collimator. Radiother Oncol 1993; 29: 317–26.
   PubMedGoogle Scholar
• Brahme A, Nilsson J, Belkic D. Biologically optimized radia-tion therapy. Acta Oncol 2001; 40: 725–34.
   Google Scholar